HEALTH● LOWAug 29 · Aug 29, 2026, 4:45 AM
FDA Approves Takeda Mimrylo For Rare Blood Disorder Polycythemia Vera
finanzen.ch · Switzerland · north america
The FDA has approved Takeda Mimrylo for the treatment of polycythemia vera, a rare blood disorder. This represents a new medical option for patients with this condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapSwitzerland and nearby eventsMore from SwitzerlandLatest stories and threat level
More in Health
HEALTH1h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR NewsHEALTH1h agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH1h ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH1h agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."Clarín